Genetics in Medicine

Papers
(The TQCC of Genetics in Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Masthead310
Elucidating the clinical spectrum and molecular basis of HYAL2 deficiency237
Editorial Board203
eP234: SERPINA1 sequencing facilitates detection of undiagnosed Alpha-1 antitrypsin deficiency170
Desperately seeking solutions151
eP033: COASY-associated pontocerebellar hypoplasia – A possible additional secondary target detectable by expanded newborn screening?138
eP162: Mosaic variant in ENG in infant with pulmonary arteriovenous malformations: Case report and review of hereditary hemorrhagic telangiectasia128
eP049: Discordant fluorescence in situ hybridization and RNASeq results in the identification of fusion partners in recurring translocations in hematological malignancies117
eP179: Expanding the phenotype of CLCN6-associated early-onset neurodegeneration98
eP169: A case report of Ververi-Brady syndrome: Expanding the genotype and phenotype92
eP290: A mosaic Angelman syndrome case with language apraxia and symptoms overlapping Prader-Willi syndrome85
Editorial Board82
OP037: Assessing the impact of expanded ACMG secondary findings recommendations on population genomic screening in the Geisinger MyCode Community Health Initiative77
Table of Contents70
OP055: Comparing error rates in disclosure of genome sequencing results between non-genetics providers and genetic counselors70
Biallelic PRMT7 pathogenic variants are associated with a recognizable syndromic neurodevelopmental disorder with short stature, obesity, and craniofacial and digital abnormalities70
eP498: Detection of congenital cytomegalovirus infection on high-risk newborn population70
Table of Contents65
Correspondence on “Elucidating the clinical and genetic spectrum of inositol polyphosphate phosphatase INPP4A-related neurodevelopmental disorder” by Rawlins et al64
ClinGen recuration of hearing loss-associated genes demonstrates significant changes in gene-disease validity over time63
Editorial Board62
Scoping review and classification of deep learning in medical genetics59
Where there is no genetic counselor: An online decision-aid supports the majority of parents’ diagnostic genomic testing choices for their children59
Educational considerations based on medical student use of polygenic risk information and apparent race in a simulated consultation58
Optical genome mapping improves clinical interpretation of constitutional copy-number gains and reduces their VUS burden56
The clinical geneticist workforce: Community forums to address challenges and opportunities56
The importance of automation in genetic diagnosis: Lessons from analyzing an inherited retinal degeneration cohort with the Mendelian Analysis Toolkit (MATK)55
Correspondence on “Genomic insights from a deeply phenotyped highly consanguineous neurodevelopmental disorders cohort” by Akter et al55
Functional genomics for curation of variants in telomere biology disorder associated genes: A systematic review54
Inherited variants in CHD3 show variable expressivity in Snijders Blok-Campeau syndrome49
Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions49
eP256: Intrafamilial variability in chromosome 2q13 microdeletion: Case report and review of the literature49
Estimation of carrier frequencies of autosomal and X-linked recessive genetic conditions based on gnomAD v4.0 data in different ancestries47
Cascade testing after exome sequencing: Retrospective analysis of linked family data at 2 US laboratories46
Expanding the phenotype and genotype spectrum of TAOK1 neurodevelopmental disorder and delineating TAOK2 neurodevelopmental disorder45
Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies45
Increasing inclusivity in precision medicine research: Views of deaf and hard of hearing individuals44
Biallelic DAW1 variants cause a motile ciliopathy characterized by laterality defects and subtle ciliary beating abnormalities44
Correspondence on “Genotypic and phenotypic spectrum of infantile liver failure due to pathogenic TRMU variants” by Vogel et al43
Masthead43
Improving racial diversity in the genomics workforce: An examination of challenges and opportunities43
Universal tumor screening in a population with MSH6- and PMS2-associated Lynch syndrome43
eP114: De novo prenatal diagnosis of X-linked Acromegaly Gigantism (X-LAG)41
eP018: Late-onset congenital erythropoietic porphyria associated with myeloid malignancy41
eP073: Interstitial deletion of 3q21 in a child with multiple congenital anomalies; Expanding the phenotype41
Calibrating variant curation by clinical context based on factors that influence patients’ tolerance of uncertainty40
eP512: Identifying clinical and psychological factors associated with genomics-related outcomes in a centralized sequencing protocol39
eP005: Complex glycerol kinase deficiency and X-linked intellectual disability39
eP462: Detection of clinically relevant exonic copy number changes in fetuses by chromosomal microarray analysis38
eP088: Diagnosing a patient with progressive myoclonic epilepsy-12 with variants of uncertain significance on exome sequencing38
eP270: Incorporating genetic services into adult kidney disease care37
eP509: Implementation and impact of dedicated inpatient genetic counselors in a children’s hospital35
eP229: A case report of a complex chromosome 8 rearrangement with partial monosomy of 8p and partial trisomy of 8q35
De novo variants are a common cause of genetic hearing loss35
OP048: The impact of route of delivery on surgical morbidity in fetuses affected by achondroplasia: A multicenter retrospective study35
Editorial Board35
eP321: Extending and adapting the functions of genetic laboratories in the continuing COVID pandemic–challenges and successes34
eP263: A pathogenic deletion at 13q32.1q33.1 presenting with bilateral sensorineural hearing loss and pigmentation anomalies, mimicking Waardenburg syndrome32
eP354: A systematic approach for applying disease-specific phenotype in clinical variant interpretation32
eP244: Rapid exome sequencing influences acute and long-term management of critically unwell children and their families32
The splicing effect of variants at branchpoint elements in cancer genes32
A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder31
Challenges for precision public health communication in the era of genomic medicine31
“The truth should not be hidden”: Experiences and recommendations of individuals making NPE discoveries through genetic genealogy databases31
eP358: Genetic findings in a cohort of patients with pulmonary arterial hypertension referred for NGS panel testing31
Genetics providers’ perspectives on the use of digital tools in clinical practice31
CFTR genotype analysis of Asians in international registries highlights disparities in the diagnosis and treatment of Asian patients with cystic fibrosis30
Characterization of central manifestations in patients with Niemann-Pick disease type C30
Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes30
Exploring Autistic adults’ perspectives on genetic testing for autism30
Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections30
Expanding SPTAN1 monoallelic variant associated disorders: From epileptic encephalopathy to pure spastic paraplegia and ataxia29
Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada29
Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome28
Correspondence on “Comparison of literature mining tools for variant classification: Through the lens of 50 RYR1 variants” by Wermers et al28
Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete results28
Rethinking agency for genetic testing intention among Latinos: Determining predictors of intention for carrier screening and cancer predisposition testing28
Long-term effects of eliglustat on skeletal manifestations in clinical trials of patients with Gaucher disease type 128
Pathogenic XPO1 variants cause a dominant neurodevelopmental disorder27
Masthead27
Pubertal growth in osteogenesis imperfecta caused by pathogenic variants in COL1A1/COL1A227
Response to Kiel and Kozaric27
Editorial Board26
Response to Shen et al.26
eP364: Lessons from pathogenicity classifications for 251 RYR1 variants associated with malignant hyperthermia susceptibility using variant curation expert panel revised criteria26
eP342: Clinical testing of SHOX gene for SHOX deficiency disorders26
Masthead26
Diagnosing, discarding, or de-VUSsing: A practical guide to (un)targeted metabolomics as variant-transcending functional tests26
Frequency of epistaxis and telangiectasia in patients with hereditary hemorrhagic telangiectasia (HHT) in comparison with the general population: Curaçao diagnostic criteria revisited26
eP153: WASF2 variants contribute to heart failure phenotypes26
eP446: High rates of ‘atypical’ panorama noninvasive prenatal screening results among consanguineous Arab American women25
eP249: Practical implementation of inpatient rapid comprehensive sequencing for critically ill pediatric patients25
eP398: Searching beyond the exons in nuclear genes: Diagnostic deep intronic and mitochondrial variants in patients with monogenic diabetes25
eP198: EIF3F compound heterozygous genotype-phenotype association25
Response to Stern25
eP006: Homocystinuria in an adolescent patient with Chr21q22.2q22.3 deletion25
eP091: Improving cytogenetic testing utilization in a tertiary care NICU through quality improvement24
OP012: Perceptions of breast and ovarian cancer risk and genetic testing among Non-Hispanic Black women24
Genome sequencing detects a wide range of clinically relevant copy-number variants and other genomic alterations24
Correspondence on “Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: A practice resource of the American College of Medical Genetics and Genomics (ACMG)” by23
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire22
eP082: Associated recessive retinitis pigmentosa caused by paternal uniparental disomy22
Noncoding variants are a rare cause of recessive developmental disorders in trans with coding variants22
Pregnant Latinas’ views of adopting exome sequencing into newborn screening: A qualitative study22
Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders22
Secondary ACMG and non-ACMG genetic findings in a multiethnic cohort of 16,713 pediatric participants22
The ACMG SF v3.0 gene list increases returnable variant detection by 22% when compared with v2.0 in the ClinSeq cohort22
Overcoming treatment implementation barriers for individuals with rare diseases using single-case experimental designs22
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics22
Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C121
Non-neoplastic causes of death in neurofibromatosis 1: A cohort study with long-term follow-up21
The opinions and experiences of people with intellectual disability regarding genetic testing and genetic medicine: A systematic review21
Evaluating the return of additional findings from the 100,000 Genomes Project: A mixed-methods study exploring participant experiences of receiving secondary findings from genomic sequencing21
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis21
Novel insights into the phenotypic spectrum and pathogenesis of Hardikar syndrome21
Awareness and use of genetic testing: An analysis of the Health Information National Trends Survey 202021
Correspondence on “Mainstreaming of clinical genetic testing: a conceptual framework” by Mackley et al21
Risk of cancer in heterozygous relatives of patients with Fanconi anemia21
Nonadherence to guidelines for genetic testing in families with ovarian cancer shows racial bias21
Screening rare genetic diagnoses for amenability to bespoke antisense oligonucleotide therapy development: A retrospective cohort study20
Biallelic variation in the choline and ethanolamine transporter FLVCR1 underlies a severe developmental disorder spectrum20
The Parent PrU: A measure to assess personal utility of pediatric genomic results20
Expanding the genetics and phenotypes of ocular congenital cranial dysinnervation disorders20
eP384: Clinical, epidemiological and genetic characteristics of children diagnosed with Multisystem Inflammatory Syndrome (MIS-C) in Kuwait20
Synostosis of joints caused by mutant FBN2 is linked to the abnormalities and misdifferentiation of articular surface cells19
Optical genome mapping and revisiting short-read genome sequencing data reveal previously overlooked structural variants disrupting retinal disease−associated genes19
eP391: Optical genome mapping for constitutional postnatal SV, CNV, and repeat array sizing: A multi-site clinical study19
Correspondence on “The evolving role of medical geneticists in the era of gene therapy: An urgency to prepare” by Vockley et al19
Correspondence on “No association between FMR1 premutation and either ADHD or anxiety in 53,707 women undergoing genetic testing for family planning purposes” by Klausner et al19
eP094: Diagnostic yield of chromosomal microarray in congenital heart disease: A single center retrospective study19
eP128: A novel CSNK1E variant in a patient with autism spectrum disorder19
OP046: Stigma manifestations impact patient and clinical outcomes in cardiogenetic care: “Sometimes it’s depressing. Sometimes I feel like giving up.”19
eP405: Clinical application of 24-hour ultra-rapid genome sequencing in a critically ill neonate19
Editorial Board19
Mapping the genetic landscape of treatable inherited metabolic disorders in a large Middle Eastern biobank19
Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study19
eP040: Breast cancer patients categorized as high-risk of recurrence and/or basal-type molecular subtype by Agendia should universally undergo germline genetic testing19
eP426: Utilization of the ACMG ACT sheets and algorithms on the ACMG website18
OP019: A tertiary care clinical sequencing program for patients with suspected immune defects: Results from the first 1000 families18
Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma18
eP078: Phenotypes and genotypes in a cohort of children with single ventricle congenital heart disease18
eP052: Coding defects in chromosomal segregation and protein targeting are central to TGCT predisposition18
eP271: Bi-allelic loss of function variant of the ACTG2 gene that proposes a potential novel mechanism for visceral myopathies18
Masthead18
eP164: A case report of neurological manifestations and failure to thrive in neurobehavioural disease caused by a variant in RFX718
OP059: Clinical impact of a targeted pharmacogenomic assessment within a cohort of individuals with suspected inborn errors of immunity18
eP328: Establishing droplet digital PCR method for assessing mitochondrial DNA content in muscle18
Validation of lung cancer polygenic risk scores in a high-risk case-control cohort17
The 2019 medical genetics workforce: A focus on laboratory geneticists17
Quantifying evidence for phenotypic specificity (PP4) for syndromic phenotypes: Large-scale integration of rare germline FH variants from diagnostic laboratory testing for HLRCC and renal cancer17
High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-1917
Natural history of TANGO2 deficiency disorder: Baseline assessment of 73 patients17
Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations17
Pancreatic cancer risk to siblings of probands in bilineal cancer settings17
Additional findings from the 100,000 Genomes Project: A qualitative study of recipient perspectives17
ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial17
Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy17
Clinical and functional heterogeneity associated with the disruption of retinoic acid receptor beta17
Automated reanalysis application to assist in detecting novel gene–disease associations after genome sequencing17
Table of Contents16
Recessive FANCM cancer syndrome with high cancer risks, chemotherapy toxicity, chromosome fragility, and gonadal failure16
Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel16
Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation G16
eP041: How long will they wait? Applying updated NCCN criteria to previously unqualified patients reveals missed opportunities for personalized cancer management16
Table of Contents16
Economic evaluation of population-based, expanded reproductive carrier screening for genetic diseases in Australia16
CIAO1 and MMS19 deficiency: A lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disorders16
De novo PHF5A variants are associated with craniofacial abnormalities, developmental delay, and hypospadias16
eP383: Mayo Clinic GeneGuide: A population-scale genetic interpretation software for reporting pathogenic and likely pathogenic variants impacting the CDC Tier1 genes16
Correspondence on “Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations” by Pantaleo et al16
Masthead16
Clinical factors associated with genetic diagnosis in suspected neurogenetic disorders in a tertiary care clinic16
Cost-effectiveness of population-wide genomic screening for Lynch Syndrome and polygenic risk scores to inform colorectal cancer screening16
eP421: Development of an in-house whole transcriptome test for evaluation of splicing VUS variants: Experience and challenges in variant interpretation15
eP376: NGS detection of NUDT15 6-bp insertion and UGT1A1 (TA) repeat polymorphism on a preventative genomics assay15
eP055: The Clinical Genome Resource (ClinGen) Somatic Cancer Clinical Domain Working Group15
eP272: Familial pathogenic variant causing osteogenesis imperfecta identified in the Puerto Rican population15
eP473: Patient attitudes and preferences about expanded noninvasive prenatal screening15
Editorial Board15
eP038: A new biochemical assay to measure plasmalogens with CLIR disease differentiation15
OP002: Secondary data analysis: Opportunities to advance genetic disease understanding and newborn screening research15
Impact of integrated translational research on clinical exome sequencing15
eP248: Impact of DNA methylation signature exploration for variants of uncertain significance within epigenetic syndromes15
eP208: GSD IX natural history and novel liver disease severity score: Multicenter international collaboration uncovers longitudinal trends in liver disease severity15
Masthead15
Mainstreaming of clinical genetic testing: A conceptual framework14
Editorial Board14
eP265: Higher rates of non-skeletal complications in achondroplasia compared to the general population: A UK matched cohort study using CPRD-GOLD database14
Response to Timothé Ménard14
Genomic testing for suspected monogenic kidney disease in children and adults: A health economic evaluation14
Genome-wide epigenetic signatures facilitated the variant classification of the PURA gene and uncovered the pathomechanism of PURA-related neurodevelopmental disorders14
The impact of genetic counselor involvement in genetic and genomic test order review: A scoping review14
The mitochondrial seryl-tRNA synthetase SARS2 modifies onset in spastic paraplegia type 414
eP154: Predictive genomic medicine for thoracic aortic aneurysm and dissection14
eP429: Factors associated with the time to complete clinical exome sequencing in a pediatric patient population14
OP040: Clinical validation of tagmentation-based genome sequencing for germline disorders14
OP016: Mini-COMET: Safety and efficacy of ≥97 weeks’ avalglucosidase alfa in infantile-onset Pompe disease participants previously treated with alglucosidase alfa14
Pathogenic variants in the paired-related homeobox 1 gene (PRRX1) cause craniosynostosis with incomplete penetrance14
A systematic review of the methodological quality of economic evaluations in genetic screening and testing for monogenic disorders14
Germline variants in HEY2 functional domains lead to congenital heart defects and thoracic aortic aneurysms14
eP034: Novel use of global untargeted metabolomics in a patient with glycogen storage disease Ib receiving off label empagliflozin treatment14
eP333: Tracking the emergence of SARS-CoV-2 variants of concern in vaccinated and unvaccinated patients14
“Doctors shouldn’t have to cheat the system”: Clinicians’ real-world experiences of the utility of genomic sequencing14
SOX11 variants cause a neurodevelopmental disorder with infrequent ocular malformations and hypogonadotropic hypogonadism and with distinct DNA methylation profile14
Genetic Determinants of Sudden Unexpected Death in Pediatrics14
Improving care for rare genetic neurodevelopmental disorders: A systematic review and critical appraisal of clinical practice guidelines using AGREE II13
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Varia13
eP332: The importance of parental sequencing depth in the setting of rapid genome sequencing13
Biallelic variants in PIGN cause Fryns syndrome, multiple congenital anomalies-hypotonia-seizures syndrome, and neurologic phenotypes: A genotype–phenotype correlation study13
Addendum: Preconception and prenatal testing of biologic fathers for carrier status; Carrier screening in individuals of Ashkenazi Jewish descent; Carrier screening for spinal muscular atrophy13
Biallelic USP14 variants cause a syndromic neurodevelopmental disorder13
Measurement of lysosomal enzyme activities: A technical standard of the American College of Medical Genetics and Genomics (ACMG)13
Reconciling diversity in health and genomic data collection with the regulation of AI in clinical genomics13
Standardizing variation: Scaling up clinical genomics in Australia13
“All doctors should be trained in that”: The co-production and mixed-methods evaluation of an educational toolkit to enable safe, high-quality genetic health care for people with intellectual disabili13
eP341: The full (mutation) picture: One-third of patients with Fragile X syndrome present with neurodevelopmental disorders without dysmorphism or family history13
eP520: Screening results in 186 any-health-status adults in primary care clinics receiving clinical NGS for 431 health risk and recessive genes13
The ClinGen Brain Malformation Variant Curation Expert Panel: Rules for somatic variants in AKT3, MTOR, PIK3CA, and PIK3R213
The Clinician-reported Genetic Testing Utility Index (C-GUIDE) for Prenatal Care: Initial evidence of content and construct validity13
The contribution of medical burden to 22q11.2 deletion syndrome quality of life and functioning13
Functional characteristics of a broad spectrum of TBX6 variants in Mayer-Rokitansky-Küster-Hauser syndrome13
Pathogenic variants in CLXN encoding the outer dynein arm docking–associated calcium-binding protein calaxin cause primary ciliary dyskinesia13
High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer13
eP330: Mosaicism for SMARCB1 or LZTR1 variants in patients with schwannomatosis in the UAB cohort13
OP011: Physician recommendations after germline sequencing in pediatric cancer patients: Texas KidsCanSeq study13
Fraud in genetic testing: Swindling the system13
A meta-analysis of diagnostic yield and clinical utility of genome and exome sequencing in pediatric rare and undiagnosed genetic diseases13
eP020: Expanding the clinical spectrum of asparagine synthetase deficiency12
eP203: Genotype/phenotype correlations in Joubert syndrome12
eP201: A phase 2 clinical trial evaluating the safety and efficacy of delandistrogene moxeparvovec for treating patients with Duchenne muscular dystrophy12
The difficulties of broad data sharing in genomic medicine: Empirical evidence from diverse participants in prenatal and pediatric clinical genomics research12
Diagnosis, treatment and disclosure: A qualitative exploration of participant challenges in a Monogenic Diabetes Registry12
Editorial Board12
Table of Contents12
Factors associated with the time to complete clinical exome sequencing in a pediatric patient population12
eP108: PPP1CB-related Noonan syndrome with loose anagen hair presenting with focal cortical dysplasia and epilepsy12
eP418: Enabling reclassification of missense variants in PKD1/2 – the power of a commercial laboratory database12
eP125: Variants in obesity-related genes in a population with early-onset obesity12
Expanding the genetic and phenotypic spectrum of ACTA2-related vasculopathies in a Dutch cohort12
OP047: Timely diagnosis of mucopolysaccharidosis: Results from an innovative physician education program with a national outreach12
Genotype-First Assessment of Presentation and Penetrance of Neurofibromatosis Type 1, Autosomal Dominant Polycystic Kidney Disease, and Marfan Syndrome Within the All of Us Research Program Cohort11
A clinical scoring system for early onset (neonatal) Marfan syndrome11
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)11
Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: Lower rates for 5 years post chemotherapy11
Table of Contents11
Severity-adjusted evaluation of liver transplantation on health outcomes in urea cycle disorders11
Masthead11
Intersectionality in a sociogenomic world: How do race, disability, socioeconomic status, and polygenic prediction interact to affect perceptions of educational trajectories?11
Health care utilization and behavior changes after workplace genetic testing at a large US health care system11
Genomics-informed neuropsychiatric care for neurodevelopmental disorders: Results from a multidisciplinary clinic11
0.1977801322937